Laura L. Johnson - Net Worth and Insider Trading
Laura L. Johnson Net Worth
The estimated net worth of Laura L. Johnson is at least $9 dollars as of 2024-05-02. Laura L. Johnson is the Director of Kintara Therapeutics Inc and owns about 60 shares of Kintara Therapeutics Inc (KTRA) stock worth over $9. Laura L. Johnson is also the Director of La Jolla Pharmaceutical Co and owns about 0 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $0. Details can be seen in Laura L. Johnson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laura L. Johnson has not made any transactions after 2021-11-22 and currently still holds the listed stock(s).
Transaction Summary of Laura L. Johnson
Laura L. Johnson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laura L. Johnson owns 3 companies in total, including Kintara Therapeutics Inc (KTRA) , La Jolla Pharmaceutical Co (LJPC) , and Odonate Inc (ODTCD) .
Click here to see the complete history of Laura L. Johnson’s form 4 insider trades.
Insider Ownership Summary of Laura L. Johnson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2021-11-22 | director |
| LJPC | La Jolla Pharmaceutical Co | 2022-08-22 | director |
| ODTCD | Odonate Inc | 2018-12-03 | director |
Laura L. Johnson Latest Holdings Summary
Laura L. Johnson currently owns a total of 2 stocks. Among these stocks, Laura L. Johnson owns 60 shares of Kintara Therapeutics Inc (KTRA) as of November 22, 2021, with a value of $9 and a weighting of 100%. Laura L. Johnson also owns 0 shares of La Jolla Pharmaceutical Co (LJPC) as of December 29, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Laura L. Johnson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2021-11-22 | 60 | 0.16 | 9 |
| LJPC | La Jolla Pharmaceutical Co | 2017-12-29 | 0 | 6.22 | 0 |
Holding Weightings of Laura L. Johnson
Laura L. Johnson Form 4 Trading Tracker
According to the SEC Form 4 filings, Laura L. Johnson has made a total of 1 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 60 shares on November 22, 2021, which cost Laura L. Johnson around $2,220.
According to the SEC Form 4 filings, Laura L. Johnson has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the sale of 10,000 shares on December 29, 2017, which brought Laura L. Johnson around $323,200.
Insider Trading History of Laura L. Johnson
- 1
Laura L. Johnson Trading Performance
GuruFocus tracks the stock performance after each of Laura L. Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laura L. Johnson is -47.4%. GuruFocus also compares Laura L. Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laura L. Johnson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laura L. Johnson's insider trading performs compared to the benchmark.
Performance of Laura L. Johnson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.29 | | | | | |
| Relative Return to S&P 500(%) | -18.58 | | | | | |
Laura L. Johnson Ownership Network
Laura L. Johnson Owned Company Details
What does Kintara Therapeutics Inc do?
Who are the key executives at Kintara Therapeutics Inc?
Laura L. Johnson is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .
Kintara Therapeutics Inc (KTRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintara Therapeutics Inc Insider Transactions
Laura L. Johnson Mailing Address
Above is the net worth, insider trading, and ownership report for Laura L. Johnson. You might contact Laura L. Johnson via mailing address: C/o La Jolla Pharmaceutical Company, La Jolla Village Drive, Suite 1070, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
